AI assistant
PYC THERAPEUTICS LIMITED — Director's Dealing 2025
Dec 22, 2025
65640_rns_2025-12-22_ae2c5dc3-bfc7-4596-9039-09d74d3522af.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | PYC Therapeutics Limited |
|---|---|
| ABN | 48 098 391 961 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Peter Coleman |
|---|---|
| Date of last notice | 18 November 2025 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest | |
| (including registered holder) | |
| Note: Provide details of the circumstances giving rise to the relevant | |
| interest. | |
| Date of change | 23/12 2025 |
| No. of securities held prior to change | Nil |
| Class | Unlisted Options with an exercise price of |
| $1.80 each expiring19 November 2028 | |
| Number acquired | 2,000,000 |
| Number disposed | - |
| Value/Consideration | Issued as part of remuneration. |
| Note: If consideration is non-cash, provide details and estimated | |
| valuation | |
| No. of securities held after change | 2,000,000 options with an exercise price of |
| $1.80 each expiring 19 November 2028 |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
Nature of change Issued pursuant to Letter of Appointment. Example: on-market trade, off-market trade, exercise of options, Refer ASX release dated 13 November 2025 issue of securities under dividend reinvestment plan, participation in buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | Nil |
|---|---|
| Nature of interest | - |
| Name of registered holder(if issued securities) | - |
| Date of change | - |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | - |
| Interest acquired | - |
| Interest disposed | - |
| Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation | - |
| Interest after change | - |
Part 3 –[+] Closed period
| art 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? | No |
| If so, was prior written clearance provided to allow thetrade to proceed during this period? | n/a |
| If prior written clearance was provided, on what date wasthis provided? | n/a |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011